Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Meta-Analysis Comparing Same-Sitting and Staged Percutaneous Coronary Intervention of Non-Culprit Artery for ST-Elevation Myocardial Infarction with Multivessel Coronary Disease.
Ueyama H, Kuno T, Yasumura K, Vengrenyuk Y, Takagi H, Barman N, Suleman J, Banning AS, Boxma-de Klerk BM, Smits PC, Kini A, Sharma SK. Ueyama H, et al. Among authors: banning as. Am J Cardiol. 2021 Jul 1;150:24-31. doi: 10.1016/j.amjcard.2021.03.043. Epub 2021 May 16. Am J Cardiol. 2021. PMID: 34011437
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.
Serruys PW, Morice MC, Kappetein AP, Colombo A, Holmes DR, Mack MJ, Ståhle E, Feldman TE, van den Brand M, Bass EJ, Van Dyck N, Leadley K, Dawkins KD, Mohr FW; SYNTAX Investigators. Serruys PW, et al. N Engl J Med. 2009 Mar 5;360(10):961-72. doi: 10.1056/NEJMoa0804626. Epub 2009 Feb 18. N Engl J Med. 2009. PMID: 19228612 Free article. Clinical Trial.
Meta-Analysis of Randomized Controlled Trials Comparing Multivessel Versus Culprit-Only Revascularization for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease Undergoing Primary Percutaneous Coronary Intervention.
El-Hayek GE, Gershlick AH, Hong MK, Casso Dominguez A, Banning A, Afshar AE, Herzog E, Tamis-Holland JE. El-Hayek GE, et al. Am J Cardiol. 2015 Jun 1;115(11):1481-6. doi: 10.1016/j.amjcard.2015.02.046. Epub 2015 Mar 12. Am J Cardiol. 2015. PMID: 25840579 Review.
Management of Multivessel Disease and Cardiogenic Shock.
Banning AS, Gershlick AH. Banning AS, et al. Interv Cardiol Clin. 2016 Oct;5(4):533-540. doi: 10.1016/j.iccl.2016.06.009. Epub 2016 Aug 13. Interv Cardiol Clin. 2016. PMID: 28582001 Review.
Contemporary considerations in left main stem treatment.
Gershlick AH, Banning A. Gershlick AH, et al. EuroIntervention. 2017 Nov 20;13(10):1144-1147. doi: 10.4244/EIJV13I10A179. EuroIntervention. 2017. PMID: 29151437 Free article. No abstract available.
Outcomes After Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting According to Lesion Site: Results From the EXCEL Trial.
Gershlick AH, Kandzari DE, Banning A, Taggart DP, Morice MC, Lembo NJ, Brown WM 3rd, Banning AP, Merkely B, Horkay F, van Boven AJ, Boonstra PW, Dressler O, Sabik JF 3rd, Serruys PW, Kappetein AP, Stone GW. Gershlick AH, et al. JACC Cardiovasc Interv. 2018 Jul 9;11(13):1224-1233. doi: 10.1016/j.jcin.2018.03.040. JACC Cardiovasc Interv. 2018. PMID: 29976358 Free article. Clinical Trial.
Long-Term Follow-Up of Complete Versus Lesion-Only Revascularization in STEMI and Multivessel Disease: The CvLPRIT Trial.
Gershlick AH, Banning AS, Parker E, Wang D, Budgeon CA, Kelly DJ, Kane PO, Dalby M, Hetherington SL, McCann GP, Greenwood JP, Curzen N. Gershlick AH, et al. Among authors: banning as. J Am Coll Cardiol. 2019 Dec 24;74(25):3083-3094. doi: 10.1016/j.jacc.2019.10.033. J Am Coll Cardiol. 2019. PMID: 31856964 Free article. Clinical Trial.
36 results